The Quadrivalent Approach to Influenza Vaccination
Author:
Open Access
- 11 July 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 208 (4) , 539-540
Abstract
(See the major article by Langley et al on pages 544–53.)Keywords
This publication has 10 references indexed in Scilit:
- Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Candidate: A Phase III Randomized Controlled Trial in ChildrenThe Journal of Infectious Diseases, 2013
- Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adultsBMC Infectious Diseases, 2013
- A Randomized Trial of Candidate Inactivated Quadrivalent Influenza Vaccine versus Trivalent Influenza Vaccines in Children Aged 3–17 YearsThe Journal of Infectious Diseases, 2013
- Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adultsVaccine, 2013
- The economic value of a quadrivalent versus trivalent influenza vaccineVaccine, 2012
- Quadrivalent Ann Arbor strain live-attenuated influenza vaccineExpert Review of Vaccines, 2012
- Immunogenicity and Safety of a Quadrivalent Live Attenuated Influenza Vaccine in ChildrenThe Pediatric Infectious Disease Journal, 2012
- Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccineVaccine, 2012
- A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adultsVaccine, 2011
- Clinical manifestations and socio-economic impact of influenza among healthy children in the communityJournal of Infection, 2011